




















Abstract:The rising prevalence of complex diseases characterised by multiple coexisting and interacting etiological processes poses critical challenges for survival analysis and precision medicine, particularly as population ageing renders mutually exclusive models increasingly untenable. We propose a competing accelerated failure time (cAFT) framework to understand the individual-specific temporal dynamics of disease competition and interaction based on a first-to-fail principle. Specifically, we introduce an individualised, time-varying winning probability to quantify the relative contributions of latent causes and provide an interpretable basis for patient stratification within distinct subtypes. Consistency and asymptotic normality are established for the maximum likelihood estimation of the parameters, with practical implementation via an expectation-maximisation (EM) algorithm. We illustrate the model's effectiveness and efficiency through numerical simulations and real-world applications, including biomarker discovery for 28-day survival in sepsis and overall survival in lung adenocarcinoma. Compared with standard AFT and Cox proportional hazards models, the cAFT model consistently improves predictive accuracy (C-index and iAUC gains of 5--10%) and reveals subtype-dependent gene effects within distinct biological pathways across heterogeneous patient subgroups. Conclusively, the cAFT model provides deeper insights into patient prognosis and potential personalised therapeutic strategies.
From: Kai Wang [view email]
[v1]
Wed, 12 Mar 2025 12:02:27 UTC (2,576 KB)
[v2]
Mon, 29 Jun 2026 04:07:50 UTC (16,464 KB)
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。